Compugen to Host Conference Call to Discuss Exclusive License Agreement with Gilead for COM503, Novel Immuno-Oncology Pre-Clinical Program Harnessing IL-18 Biology
Conference call today, December 19, 2023, 8:30 AM ET to discuss the license agreement HOLON, Israel, Dec. 19, 2023 /PRNewswire/ — Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that it wi
MESCIUS inc. Releases Wijmo 2023 v2
PITTSBURGH, Dec. 19, 2023 /PRNewswire/ — MESCIUS inc., a global provider of award-winning enterprise software development tools, is pleased to announce the Wijmo 2023 v2 release. The final release of 2023 includes significant accessibility enhancements, FlexGrid improvements, and more. The mai
Lufthansa Group to Buy up to 100 737 MAX Jets in First Boeing Single-Aisle Order in Nearly 30 Years
SEATTLE, Dec. 19, 2023 /PRNewswire/ — Boeing [NYSE: BA] and the Lufthansa Group today announced a landmark 737 MAX order for up to 100 jets that will see Europe’s largest airline group restore the Boeing 737 family into its fleet. The commitment includes a firm order for 40 737-8 airplan
Compugen will be Eligible to Receive $10 Million Milestone Payment upon Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer
Dosing of first patient in Phase 3 trial of rilvegostomig, a PD-1/TIGIT bispecific antibody, will trigger $10 million milestone payment from AstraZeneca HOLON, Israel, Dec. 19, 2023 /PRNewswire/ — Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a
Alora Pharmaceuticals, LLC announces the availability of Once-Daily Relexxii® for the treatment of Attention Deficit Hyperactivity Disorder (ADHD)
ALPHARETTA, Ga., Dec. 19, 2023 /PRNewswire/ — Alora Pharmaceuticals, LLC, the parent company of Vertical Pharmaceuticals, LLC, announced today the commercial availability of Relexxii® (methylphenidate hydrochloride extended-release tablets). Relexxii is a once-daily central nervous system (CN
Driven Brands announces appointment of Damien Harmon to Board of Directors
Company adds new independent director CHARLOTTE, N.C., Dec. 19, 2023 /PRNewswire/ — Driven Brands Holdings (NASDAQ: DRVN), today announced the election of Damien Harmon to its Board of Directors, effective January 1, 2024. Harmon will also serve as a member of the Compensation Committee. ̶
Panda Trading Systems and Pay.com Unveil Seamless Integration, Elevating Trading Experience for Brokers and their Clients
Strategic Partnership Delivers Unparalleled Trading Capabilities by Merging Pay.com’s Advanced Payment Solutions with Panda Trading Systems’ Flagship Platform HAIFA, Israel, Dec. 19, 2023 /PRNewswire/ — Panda Trading Systems, a fintech company with over 17 years of experience in p
Global Luxury Car Market Forecast to 2028 – Increasing Number of High Net Worth Individuals (HNWI) and Ultra HNWIs Drives Demand
DUBLIN, Dec. 19, 2023 /PRNewswire/ — The “Global Luxury Car Market: Analysis By Volume, By Price Band (Entry & Mid-Level Luxury and Ultra Luxury), By Body Type (SUV, Sedan, Sports), By Propulsion Type (Non-BEV and BEV) Size and Trends and Forecast up to 2028” report has been
O3 Mining Announces Election to Issue Common Shares in Satisfaction of Convertible Debenture Interest Obligation
TSXV:OIII | OTCQX:OIIIF – O3 Mining TORONTO, Dec. 19, 2023 /PRNewswire/ – O3 Mining Inc. (TSXV: OIII) (OTCQX: OIIIF) (“O3 Mining” or the “Corporation”) announces that in accordance with the terms of the senior unsecured convertible debenture issued on June 19, 202
Consumers Energy Continues Billion-Dollar Natural Gas Investment to Reduce Long-Term Costs for Customers
Replacing aging infrastructure results in safer, more affordable natural gas JACKSON, Mich., Dec. 19, 2023 /PRNewswire/ — Consumers Energy is continuing its $1 billion annual investment in the company’s natural gas delivery system as part of its Natural Gas Delivery Plan, resulting in mi
